What medications are used before intubation in emergency and elective settings, considering patient's medical history and health status?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Intubation in Emergency and Elective Settings

For rapid sequence intubation (RSI) in both emergency and elective settings, use a sedative-hypnotic agent (ketamine, etomidate, or propofol) followed immediately by a neuromuscular blocking agent (succinylcholine 1-1.5 mg/kg or rocuronium 0.9-1.2 mg/kg), with drug selection based on hemodynamic stability and contraindications. 1, 2

Core RSI Medication Protocol

Sedative-Hypnotic Induction Agents

A sedative-hypnotic agent must always be administered when using a neuromuscular blocking agent to prevent awareness during paralysis. 1, 2

The three primary induction agents are:

  • Ketamine (1-2 mg/kg IV): Increasingly favored in most circumstances due to sympathomimetic properties that maintain hemodynamic stability, making it particularly valuable in hemodynamically unstable patients 1, 2, 3

  • Etomidate (0.2-0.4 mg/kg IV): Provides relatively stable hemodynamics and may produce less hypotension than ketamine in patients with shock or sepsis, though evidence is retrospective 1, 2, 3, 4

  • Propofol (2 mg/kg IV): Suppresses airway reflexes more effectively than other agents but causes vasodilation and hypotension, requiring caution in unstable patients 1, 2

Co-induction with rapidly-acting opioids (fentanyl 100-150 mcg or sufentanil 10-15 mcg) enables lower hypnotic doses, promoting cardiovascular stability and minimizing intracranial pressure changes. 1

Neuromuscular Blocking Agents (NMBAs)

Use of an NMBA reduces intubation complications in critically ill patients and is strongly recommended. 1, 2

  • Succinylcholine (1-1.5 mg/kg IV): First-line agent for RSI in patients with vital signs of distress, providing rapid onset (median 1 minute to intubating conditions) but with numerous contraindications including life-threatening hyperkalemia 1, 2

  • Rocuronium (0.9-1.2 mg/kg IV): Use when succinylcholine is contraindicated; provides similar intubating conditions to succinylcholine at these doses with onset in less than 2 minutes 1, 2, 5

  • Sugammadex must be immediately available when rocuronium is used to reverse neuromuscular blockade in "cannot intubate/cannot oxygenate" scenarios, though reversal does not guarantee airway patency 1, 3

Emergency vs. Elective Considerations

Emergency Setting (ICU/ED)

Modified RSI is emphasized for critically ill patients at risk of aspiration, incorporating preoxygenation, optimal positioning (semi-Fowler), and precautions against pulmonary aspiration. 1, 2

  • Preoxygenation strategies: Use noninvasive positive pressure ventilation (NIPPV) for severely hypoxemic patients (PaO2/FiO2 < 150) or high-flow nasal oxygen when difficult laryngoscopy is anticipated 1, 2

  • Medication-assisted preoxygenation (delayed sequence intubation): For agitated, delirious, or combative patients unable to tolerate preoxygenation devices, administer ketamine (1-1.5 mg/kg IV) to achieve dissociative state, allow 3 minutes of preoxygenation, then proceed with NMBA 2, 6

  • Facemask ventilation with CPAP is recommended before intubation attempts and between attempts when hypoxia occurs, despite traditional teaching to avoid ventilation 1

Elective Setting (Operating Room)

Standard RSI dosing applies with lower doses acceptable when conditions are optimal:

  • Rocuronium 0.6 mg/kg provides intubating conditions in median 1 minute with 31 minutes clinical duration under opioid/nitrous oxide/oxygen anesthesia 5

  • Lower dose rocuronium 0.45 mg/kg achieves intubation in median 1.3 minutes with 22 minutes clinical duration 5

Critical Pitfalls and Caveats

Contraindications to Succinylcholine

Avoid succinylcholine in patients with: 1

  • Hyperkalemia or conditions predisposing to hyperkalemia (burns >24 hours old, crush injuries, denervation injuries, prolonged immobilization)
  • Malignant hyperthermia history
  • Neuromuscular disorders

Hemodynamic Instability

Include a cardiovascular protocol component defining conditions for fluid challenge and early catecholamine administration to decrease cardiovascular complications. 1, 2

  • All sedatives can cause vasodilation, hypotension, and bradycardia by abolishing sympathetic tone 2
  • Ketamine's sympathomimetic properties make it preferred in shock states, though some evidence suggests higher hypotension rates (18.3% vs 12.4% with etomidate) 6

Medication Administration Sequence

Administer the sedative-hypnotic agent before or simultaneously with the NMBA—never paralyze without sedation. 2, 6

  • Failure to provide adequate sedation before paralysis results in awareness during paralysis in approximately 2.6% of emergency department intubations 6
  • Recent evidence suggests administering the NMBA first may reduce time to intubation by 6 seconds without increased awareness, though either order is acceptable 7

Special Populations

  • Obese patients: Dose rocuronium based on actual body weight, not ideal body weight, to achieve adequate intubating conditions 5

  • Geriatric patients: No dose adjustment needed for rocuronium; recovery times from 25% to 75% are not prolonged 5

  • Obstetric patients (Cesarean section): Rocuronium 0.6 mg/kg is NOT recommended for rapid sequence induction as it results in poor or inadequate intubating conditions in this population 5

Post-Intubation Management

  • Apply recruitment maneuver and PEEP ≥5 cmH₂O after intubation in hypoxemic patients 2, 6
  • Confirm tube placement with waveform capnography 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rapid Sequence Intubation in Emergency Situations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Essential Equipment and Medications for Rapid Sequence Intubation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Intubation with Succinylcholine, Ketamine, and Midazolam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug Order in Rapid Sequence Intubation.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2019

Related Questions

What are the recommended drugs for intubation in a typical adult patient in the Emergency Room (ER) setting?
What is the recommended administration rate for rapid intubation drugs, such as etomidate (sedative) and succinylcholine (neuromuscular blocking agent) or rocuronium (neuromuscular blocking agent)?
What are the recommended induction and paralytic drugs with dosing for 5 different rapid sequence intubation (RSI) case scenarios?
Do you induce paralysis first in Rapid Sequence Intubation (RSI)?
What is the recommended regimen for smooth intubation?
What is the mechanism of the Bezold-Jarisch reflex in patients undergoing neuroaxial anesthesia?
Is a 60-70 year old man with chronic venous insufficiency, a varicose ulcer on the left ankle, and pretibial edema on the right leg, with normal heart rate (HR) and blood pressure (BP), contraindicated for Physical Medicine and Rehabilitation (PM&R) admission and balneotherapy, specifically immersion in mineral water at 36-37°C?
What is the role of immunotherapy in a patient with unresectable stage 4 cholangiocarcinoma and low Microsatellite Instability (MSI)?
What are the implications and management of a low stroke volume index (SVI) in a patient with S1 radiculopathy and partial numbness of all toes?
What is the best antihistamine for a patient with acute upper airway cough syndrome, considering age, weight, and potential drug allergies or interactions?
What is the best course of action for a 46-year-old female patient with recurrent fever, joint pain, hyperthyroidism (previously treated with Methimazole), chronic acid reflux (on Omeprazole), and a history of pneumonia, who is allergic to most painkillers except Paracetamol (acetaminophen)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.